Reporting guidelines are recommendations to help write up research clearly.
Your research will be used by people from different disciplines and backgrounds for decades to come. Reporting guidelines are community-created recommendations for describing what you did and what you found so that everyone can understand, repeat, apply, and synthesise your work. Although they recommend information to include in your manuscript, they don’t dictate how to order that information.
Most reporting guidelines consist of the full guidance (sometimes called an Explanation and Elaboration document) and a checklist. The full guidance provides detailed explanations and examples for each item, and the checklist allows you to demonstrate adherence to editors.
You can use reporting guidelines throughout your research process. However you use reporting guidelines, please cite them.
Writing manuscripts
Write confidently using a reporting guideline to quickly turn a blank page into a thorough and impactful manuscript.
Checking
Use a reporting checklist to demonstrate to an editor or peer reviewer that you have included everything. Many journals require completed checklists at submission.
Writing applications
Reporting guidelines can help you write funding applications, ethics applications, and protocols, but they won’t make design decisions for you!
Reporting guidelines are neither design nor quality appraisal tools.
Although reporting guidelines recommend information to include when writing up research, they do not mandate how to design research. Similarly, when reviewing literature, although you can use reporting guidelines to assess whether a manuscript is well reported, you cannot use them to appraise whether that study is well designed.
Version: CARE 2013 v1.1. This website shows the latest version of CARE, first published in 2013, and updated here for usability.
Journals endorsing CARE: 400+
Applicability criteria
Commonly used reporting guidelines
| STROBE | Observational Studies |
| PRISMA | Systematic reviews of trials |
| PRISMA-P | Systematic review protocols |
| CONSORT | Randomised trials |
| SPIRIT | Randomised trial protocols |
| SRQR | Qualitative Research |
| CARE | Case Reports |
| STARD | Diagnostic studies |
| TRIPOD+AI | Prediction Models |
| ARRIVE | Animal Research |
| SQUIRE | Quality Improvement |
| CHEERS | Economic Evaluations |
| Search all |
Summary of guidance
Although you should describe all items below, you can decide how to order and prioritize items most relevant to your study, findings, context, and readership whilst keeping your writing concise. You can read how CARE was developed in the FAQs.
| Item name | What to write |
| Sections | |
| 1. Title | The area of focus and “case report” should appear in the title. |
| 2. Keywords | The key elements of this case in 2–5 words. |
| 3. Abstract | 3a – Introduction: What does this case add? 3b – Case presentation:
3c – Conclusion: What are the main “take-away” lessons from this case? |
| 4. Introduction | Brief background summary of the case referencing the relevant medical literature. |
| 5a. Patient information | 5a – Demographic information of the patient (age, gender, ethnicity, occupation). 5b – Main symptoms of the patient (chief complaint). 5c – Medical, family, and psychosocial history—including lifestyle and genetic information whenever possible, details about relevant comorbidities, and past interv… |
| 6. Clinical findings | Describe the relevant physical examination (PE) findings. |
| 7. Timeline | Depict important date and times in this case (table or figure). |
| 8. Diagnostic assessment | 8a – Diagnostic methods (e.g., physical examination, laboratory testing, imaging, questionnaires) 8b – Diagnostic challenges (e.g., financial, language, or cultural) 8c – Diagnostic reasoning including other diagnoses considered 8d – Prognostic characteristics (e.g., staging) where applicable. |
| 9. Therapeutic Intervention | 9a – Types of intervention (e.g., pharmacologic, surgical, preventive, self-care) 9b – Administration (e.g., dosage, strength, duration) 9c – Changes in intervention (with rationale). |
| 10. Follow up and outcomes | 10a – Clinician and patient-assessed outcomes 10b – Important follow-up test results (positive and negative) 10c – Intervention adherence and tolerability (and how this was assessed) 10d – Adverse and unanticipated events. |
| 11. Discussion | Discussion (including conclusion): 11a – Strengths and limitations of the management of this case 11b – Relevant medical literature 11c – Rationale for conclusions (including assessment of cause and effect) 11d – Main “take-away” lessons of this case report. |
| 12. Patient perspective | When appropriate patients should share their perspectives on the treatments they received. |
| 13. Informed consent | Did the patient give informed consent? Please provide if requested. |
Training and Support
The UK EQUATOR Centre runs training on how to write using reporting guidelines.